1. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer
   Theresa A Lawrie et al, 2015, Cochrane Database of Systematic Reviews CrossRef
2. Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study
   Mingchen Ba et al, 2020, Medicine CrossRef
3. Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy
   Mingchen Ba et al, 2019, Oncology Letters CrossRef
4. A Palliative Approach to Management of Peritoneal Carcinomatosis and Malignant Ascites
   Josh Bleicher et al, 2021, Surgical Oncology Clinics of North America CrossRef
5. Intrapleural hyperthermic perfusion using distilled water at 48 °C for malignant pleural effusion
   Mingchen Ba et al, 2013, Journal of Cancer Research and Clinical Oncology CrossRef
6. Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites
   Mingchen Ba et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef
7. Hyperthermic Intraperitoneal Perfusion Chemotherapy and Cytoreductive Surgery for Controlling Malignant Ascites From Ovarian Cancer
   Mingchen Ba et al, 2016, International Journal of Gynecologic Cancer CrossRef
8. Port-Site Metastases and Chimney Effect of B-Ultrasound-Guided and Laparoscopically-Assisted Hyperthermic Intraperitoneal Perfusion Chemotherapy
   Ming-Chen Ba et al, 2017, Yonsei Medical Journal CrossRef
9. Terapia intraperitoneal paliativa en ascitis maligna refractaria
   Mauricio Antonio Castaño Cárcamo et al, 2018, Revista Colombiana de Cancerología CrossRef
10. Palliative and End-of-Life Treatment
    Robert S. Krouse et al, 2018, Rectal Cancer CrossRef
11. Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study
    Klaus Pietzner et al, 2014, Medical Oncology CrossRef
12. Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection
    Mingchen Ba et al, 2017, Oncology Reports CrossRef
13. Safety and Effectiveness of High-Precision Hyperthermic Intraperitoneal Perfusion Chemotherapy in Peritoneal Carcinomatosis: A Real-World Study
    Mingchen Ba et al, 2021, Frontiers in Oncology CrossRef
14. Patients’ perspectives towards malignant ascites: results of a prospective observational trial regarding expectations, characteristics and quality of life—a study of the North-Eastern-German Society of Gynecological Oncology
    Robert Armbrust et al, 2019, Archives of Gynecology and Obstetrics CrossRef
15. Massive neoplastic ascites
    Stefano Guadagni, 2023, Il Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons CrossRef
16. Development of a high-precision bladder hyperthermic intracavitary chemotherapy device for bladder cancer and pharmacokinetic study
    Mingchen Ba et al, 2019, BMC Urology CrossRef
17. Effects of intracavitary administration of elemene combined with nedaplatin on malignant pleural effusion
    Ke Hong Chen et al, 2022, Bulletin du Cancer CrossRef
18. The efficacy of traditional chinese medicine combined with hyperthermic intraperitoneal chemotherapy for malignant ascites: A systematic review and meta-analysis
    Zhixian Lin et al, 2022, Frontiers in Pharmacology CrossRef
19. Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial
    Lili Liu et al, 2023, International Journal of Hyperthermia CrossRef
20. Palliation of malignant ascites
    Caitlin Hodge et al, 2019, Journal of Surgical Oncology CrossRef